DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde


Slamon D, Neven P, Chia S. et al.
Overall survival results of the Phase III MONALEESA-3 trial of postmenopausal patients with hormone receptor-positive human-epidermal growth factor-2-negative advanced breast cancer treated with fulvestrant plus/minus ribociclib.

Ann Oncol 2019;
30 (Suppl. 05) v851-v934

Download Bibliographical Data

Search in: